NCT06358287

Brief Summary

Chronic pain continues to be a major health issue, creating a significant societal burden, as it is an independent risk factor for opioid use disorder (OUD) and deaths. Acute pain episodes can often engender OUD due to lack of effective strategies to treat pain and prevent the transition to chronic pain. One potential non-opioid method for pain relief is auriculotherapy (AT), where acupuncture-like treatment is administered to the ear. The objective of this pilot study is to illustrate that AT-related brain effects can be found using functional connectivity MRI (fcMRI) in patients with low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 7, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

April 4, 2024

Last Update Submit

April 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Default Mode Network (DMN)-to-Anterior Cingulate Cortex (ACC) connectivity

    Group average difference in connectivity will be calculated as pre-treatment vs. post-treatment statistical contrasts. Connectivity change will have a threshold at the connection level with p \< 0.001. In this framework, a positive T-Score indicates greater connectivity before treatment (a decrease in connectivity after treatment).

    Day 3 of participation

Secondary Outcomes (3)

  • Brief Pain Inventory (BPI) Severity Scores MRI #1

    Day 3 of participation

  • BPI Pain Severity Scores MRI #2

    Day 3 of participation

  • General Anxiety Disorder-7 (GAD-7) Scoring

    Day 3 of participation

Study Arms (1)

Cryogenic Auriculotherapy Treatment

EXPERIMENTAL

Compressed nitrogen is used to create a 'cryogenic needle', using a cryopunctor device. An orifice is placed in appropriate acupoint and nitrogen flow is used to cool and activate the point. This will occur on each ear with the following points being targeted: Omega 2, Omega, spine location point, and 3 points of the pain pathway including the sensory master point (SMP), the master point of the reticule (MPR), and the thalamus (T) as well as the corpus callosum (CC) point, the amygdala, rhinencephalon, hippocampus, FSHLH, ACTH, anterior and posterior white commissure points, and the corresponding sympathetic sensory and motor nerve points.

Procedure: cryogenic auriculotherapy

Interventions

Compressed nitrogen is used to create a 'cryonic needle', using a cryopunctor device. An orifice is placed in appropriate acupoint and nitrogen flow is used to cool and activate the point.

Cryogenic Auriculotherapy Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and above.
  • Experiencing low back pain for \> 1 month and seeking treatment.
  • Literate for reading and writing in English, decision competent, willing and able to provide written informed consent, and able to complete the study's schedule of assessments.

You may not qualify if:

  • Subjects under 18 years of age.
  • History of claustrophobia.
  • Having non-MRI safe metallic or foreign objects in their body.
  • History of dementia.
  • History of sensory or motor deficits that preclude participation in pain fMRI.
  • History of clinically unstable systemic illness that is judged to interfere with the study.
  • Pregnancy or the intent to become pregnant during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Montefiore

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Keith Vogt, MD, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 10, 2024

Study Start

July 15, 2021

Primary Completion

November 7, 2022

Study Completion

November 7, 2022

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

No plans to share this preliminary data.

Locations